FDC receives EIR for Aurangabad facility

FDC has received an Establishment Inspection Report (EIR) for its manufacturing facility located at B-8, MIDC Industrial Area, Waluj, Aurangabad, Maharashtra, which was inspected from August 10, 2018 to August 16, 2018 by US Food and Drug Administration (USFDA).

The facility is considered to be acceptable with regards to current Good Manufacturing Practices (GMPs) and the inspection stands closed.

FDC is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).

BREAKING NEWS:
Get 365-day plans under ₹2000 before price hike! IPL 2026: Vaibhav Sooryavanshi Leads in Sixes! Rajasthan Royals lose despite Sooryavanshi’s fiery innings: Key culprits!